Group 1 - Zoetis Inc. primarily operates in the companion animal sector, focusing on high-growth and high-margin areas such as dermatology, parasiticides, and osteoarthritis pain management for cats and dogs [1]

Core Viewpoint - Wall Street analysts anticipate Zoetis (ZTS) to report quarterly earnings of $1.61 per share, reflecting a year-over-year increase of 3.2%, with revenues expected to reach $2.4 billion, up 1.7% from the previous year [1] Revenue Estimates - Analysts predict 'Revenues- Contract Manufacturing & Human Health' will reach $21.18 million, indicating a year-over-year change of +17.7% [4] - 'Revenues- Livestock' is expected to be $625.62 million, suggesting a decline of -9.9% year over year [4] - 'Revenues- Companion Animal' is projected to reach $1.76 billion, reflecting a year-over-year increase of +6.7% [4] Product Category Revenue Projections - 'Revenues by major product category- Vaccines' is estimated at $451.72 million, indicating a change of +1.5% from the year-ago quarter [5] - 'Revenues by major product category- Parasiticides' is expected to be $638.60 million, reflecting a change of +6.4% from the previous year [5] - 'Revenues by major product category- Medicated feed additives' is projected at $5.00 million, indicating a significant decline of -93.2% from the prior-year quarter [6] Geographic Revenue Estimates - 'Geographic Revenues- U.S.' is forecasted to reach $1.33 billion, indicating a year-over-year change of +1.7% [6] - 'Geographic Revenues- International Revenue' is expected to be $1.05 billion, reflecting a year-over-year change of +1.3% [6] - 'Geographic Revenues- International- Livestock' is projected at $438.42 million, indicating a decline of -5.9% from the prior-year quarter [7] - 'Geographic Revenues- International- Companion Animal' is expected to reach $618.49 million, reflecting a year-over-year increase of +8.7% [7] - 'Geographic Revenues- U.S.- Livestock' is forecasted to be $202.16 million, indicating a decline of -11.3% from the previous year [8] - 'Geographic Revenues- U.S.- Companion Animal' is projected at $1.15 billion, reflecting a year-over-year change of +6.2% [8] Stock Performance - Zoetis shares have decreased by -6.5% over the past month, contrasting with the Zacks S&P 500 composite's increase of +2.7% [8]